The incidence of nonmelanoma skin cancers (NMSC), including cutaneous squamous cell carcinomas (CSCC) and basal cell carcinomas (BCC), is increasing globally. Although these cancers are treatable with surgery or radiotherapy, locally advanced or metastatic forms of these carcinomas are life-threatening, difficult to treat, are not amenable to those standard options, and historically, have had few treatment options. Greater knowledge of the role of the immune system in the development of cancer, and of the role of programmed death-1 (PD-1) in evading immune clearance, has led to the study of PD-1 and PD-L1 inhibitors in the management of advanced and metastatic NMSCs. This research has led to the approval of a checkpoint inhibitor as the first treatment specifically for advanced CSCC and the continued development of checkpoint inhibitors for treating advanced BCC. Oncologists need to be aware of what constitutes a thorough diagnostic evaluation and accurate staging of patients to develop more effective individualized, evidence-based management plans. In addition, oncologists need to understand current evidence regarding the use of immunotherapies such as checkpoint inhibitors.

Register Here:
https://www.rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/

FREE! Complete at your own pace, available online anytime! 

Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

Take advantage of this unique masterclass series designed exclusively for healthcare leaders

What you'll get:

• Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

•  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

•  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

Each masterclass comes with a workbook to guide your learning experience. 

This activity can be taken anytime.

Register here: https://www.rockpointe.com/courses/pustular-psoriasis-recognizing-and-treating-a-rare-but-serious-disease-2/

Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

Personalized Approaches to HER2-Positive Breast Cancer Treatment



This activity can be taken at any time. CME available at no cost. 


Register here: https://learning.rockpointe.com/a/GHNXRO?utm_source=sms&utm_medium=email

This activity, Personalized Approaches to HER2-Positive Breast Cancer Treatment, will provide oncology clinicians with information on the most recent treatments for HER2-positive breast cancer, expert recommendations for treatment selection and sequencing, and how to identify and treat HER2-positive patients with low HER2 expression.

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

The incidence of nonmelanoma skin cancers (NMSC), including cutaneous squamous cell carcinomas (CSCC) and basal cell carcinomas (BCC), is increasing globally. Although these cancers are treatable with surgery or radiotherapy, locally advanced or metastatic forms of these carcinomas are life-threatening, difficult to treat, are not amenable to those standard options, and historically, have had few treatment options. Greater knowledge of the role of the immune system in the development of cancer, and of the role of programmed death-1 (PD-1) in evading immune clearance, has led to the study of PD-1 and PD-L1 inhibitors in the management of advanced and metastatic NMSCs. This research has led to the approval of a checkpoint inhibitor as the first treatment specifically for advanced CSCC and the continued development of checkpoint inhibitors for treating advanced BCC. Oncologists need to be aware of what constitutes a thorough diagnostic evaluation and accurate staging of patients to develop more effective individualized, evidence-based management plans. In addition, oncologists need to understand current evidence regarding the use of immunotherapies such as checkpoint inhibitors.

Register Here:
https://www.rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

FREE! Complete at your own pace, available online anytime! 

Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

Take advantage of this unique masterclass series designed exclusively for healthcare leaders

What you'll get:

• Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

•  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

•  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

Each masterclass comes with a workbook to guide your learning experience. 

This course can be taken at any time. 


Nontuberculous Mycobacteria Lung Disease: Management Strategies for Advanced Practice Providers will address the gaps in NTM-LD care by reviewing current evidence-based criteria for diagnosis and recommendations for treatment. Content will be developed by expert physicians and APPs who manage patients with NTM-LD daily and understand the barriers and issues that APPs confront in the complex nature of NTM diagnosis and treatment.

Register Here: 
https://www.rockpointe.com/courses/nontuberculous-mycobacteria-lung-disease-management-strategies-for-advanced-practice-providers-2/?utm_source=sms

Improving Cardiovascular Outcomes in T2DM: Personalizing Antihyperglycemic Therapy

The educational program Improving Cardiovascular Outcomes in T2DM: Personalizing Antihyperglycemic Therapy will familiarize primary care physicians with the pathophysiology of CVD in T2DM, results of cardiovascular outcomes trials of antihyperglycemics, and recommendations from several societies regarding the use of these agents in patients with T2DM who have or are at risk for CVD.

CME Available

Personalized Approaches to HER2-Positive Breast Cancer Treatment



This activity can be taken at any time. CME available at no cost. 


Register here: https://learning.rockpointe.com/a/GHNXRO?utm_source=sms&utm_medium=email

This activity, Personalized Approaches to HER2-Positive Breast Cancer Treatment, will provide oncology clinicians with information on the most recent treatments for HER2-positive breast cancer, expert recommendations for treatment selection and sequencing, and how to identify and treat HER2-positive patients with low HER2 expression.

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

The incidence of nonmelanoma skin cancers (NMSC), including cutaneous squamous cell carcinomas (CSCC) and basal cell carcinomas (BCC), is increasing globally. Although these cancers are treatable with surgery or radiotherapy, locally advanced or metastatic forms of these carcinomas are life-threatening, difficult to treat, are not amenable to those standard options, and historically, have had few treatment options. Greater knowledge of the role of the immune system in the development of cancer, and of the role of programmed death-1 (PD-1) in evading immune clearance, has led to the study of PD-1 and PD-L1 inhibitors in the management of advanced and metastatic NMSCs. This research has led to the approval of a checkpoint inhibitor as the first treatment specifically for advanced CSCC and the continued development of checkpoint inhibitors for treating advanced BCC. Oncologists need to be aware of what constitutes a thorough diagnostic evaluation and accurate staging of patients to develop more effective individualized, evidence-based management plans. In addition, oncologists need to understand current evidence regarding the use of immunotherapies such as checkpoint inhibitors.

Register Here:
https://www.rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

FREE! Complete at your own pace, available online anytime! 

Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

Take advantage of this unique masterclass series designed exclusively for healthcare leaders

What you'll get:

• Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

•  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

•  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

Each masterclass comes with a workbook to guide your learning experience. 

Personalized Approaches to HER2-Positive Breast Cancer Treatment



This activity can be taken at any time. CME available at no cost. 


Register here: https://learning.rockpointe.com/a/GHNXRO?utm_source=sms&utm_medium=email

This activity, Personalized Approaches to HER2-Positive Breast Cancer Treatment, will provide oncology clinicians with information on the most recent treatments for HER2-positive breast cancer, expert recommendations for treatment selection and sequencing, and how to identify and treat HER2-positive patients with low HER2 expression.

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

FREE! Complete at your own pace, available online anytime! 

Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

Take advantage of this unique masterclass series designed exclusively for healthcare leaders

What you'll get:

• Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

•  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

•  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

Each masterclass comes with a workbook to guide your learning experience. 

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

This course can be taken at any time. 


Nontuberculous Mycobacteria Lung Disease: Management Strategies for Advanced Practice Providers will address the gaps in NTM-LD care by reviewing current evidence-based criteria for diagnosis and recommendations for treatment. Content will be developed by expert physicians and APPs who manage patients with NTM-LD daily and understand the barriers and issues that APPs confront in the complex nature of NTM diagnosis and treatment.

Register Here: 
https://www.rockpointe.com/courses/nontuberculous-mycobacteria-lung-disease-management-strategies-for-advanced-practice-providers-2/?utm_source=sms

Personalized Approaches to HER2-Positive Breast Cancer Treatment



This activity can be taken at any time. CME available at no cost. 


Register here: https://learning.rockpointe.com/a/GHNXRO?utm_source=sms&utm_medium=email

This activity, Personalized Approaches to HER2-Positive Breast Cancer Treatment, will provide oncology clinicians with information on the most recent treatments for HER2-positive breast cancer, expert recommendations for treatment selection and sequencing, and how to identify and treat HER2-positive patients with low HER2 expression.

ECHO MS increases the capacity of neurologists and other healthcare providers to diagnose and manage individuals with multiple sclerosis. This CME program follows Project ECHO’s evidence-based tele-mentoring model and establishes a peer-to-peer knowledge sharing network. Each ECHO MS session features a brief didactic and two case discussions. The goal of ECHO MS is to improve overall health outcomes for individuals with MS.

• Mountain Hub – Rocky Mountain MS Center at the University of Colorado
  • 1st & 3rd Thursdays | 12:00 – 1:00 PM MT | Sept. 15, 2022 – Mar. 2, 2023 (12 CME)

REGISTER HERE: https://secure.nationalmssociety.org/site/SSurvey;jsessionid=00000000.app30052a?NONCE_TOKEN=588242FF986DCBB0F63BBEED65E468CF&ACTION_REQUIRED=URI_ACTION_USER_REQUESTS&SURVEY_ID=95853

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

FREE! Complete at your own pace, available online anytime! 

Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

Take advantage of this unique masterclass series designed exclusively for healthcare leaders

What you'll get:

• Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

•  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

•  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

Each masterclass comes with a workbook to guide your learning experience. 

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

Personalized Approaches to HER2-Positive Breast Cancer Treatment



This activity can be taken at any time. CME available at no cost. 


Register here: https://learning.rockpointe.com/a/GHNXRO?utm_source=sms&utm_medium=email

This activity, Personalized Approaches to HER2-Positive Breast Cancer Treatment, will provide oncology clinicians with information on the most recent treatments for HER2-positive breast cancer, expert recommendations for treatment selection and sequencing, and how to identify and treat HER2-positive patients with low HER2 expression.

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

ECHO MS increases the capacity of neurologists and other healthcare providers to diagnose and manage individuals with multiple sclerosis. This CME program follows Project ECHO’s evidence-based tele-mentoring model and establishes a peer-to-peer knowledge sharing network. Each ECHO MS session features a brief didactic and two case discussions. The goal of ECHO MS is to improve overall health outcomes for individuals with MS.

• Mountain Hub – Rocky Mountain MS Center at the University of Colorado
  • 1st & 3rd Thursdays | 12:00 – 1:00 PM MT | Sept. 15, 2022 – Mar. 2, 2023 (12 CME)

REGISTER HERE: https://secure.nationalmssociety.org/site/SSurvey;jsessionid=00000000.app30052a?NONCE_TOKEN=588242FF986DCBB0F63BBEED65E468CF&ACTION_REQUIRED=URI_ACTION_USER_REQUESTS&SURVEY_ID=95853

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

FREE! Complete at your own pace, available online anytime! 

Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

Take advantage of this unique masterclass series designed exclusively for healthcare leaders

What you'll get:

• Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

•  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

•  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

Each masterclass comes with a workbook to guide your learning experience. 

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course

Personalized Approaches to HER2-Positive Breast Cancer Treatment



This activity can be taken at any time. CME available at no cost. 


Register here: https://learning.rockpointe.com/a/GHNXRO?utm_source=sms&utm_medium=email

This activity, Personalized Approaches to HER2-Positive Breast Cancer Treatment, will provide oncology clinicians with information on the most recent treatments for HER2-positive breast cancer, expert recommendations for treatment selection and sequencing, and how to identify and treat HER2-positive patients with low HER2 expression.

This course can be taken at any time. 


Nontuberculous Mycobacteria Lung Disease: Management Strategies for Advanced Practice Providers will address the gaps in NTM-LD care by reviewing current evidence-based criteria for diagnosis and recommendations for treatment. Content will be developed by expert physicians and APPs who manage patients with NTM-LD daily and understand the barriers and issues that APPs confront in the complex nature of NTM diagnosis and treatment.

Register Here: 
https://www.rockpointe.com/courses/nontuberculous-mycobacteria-lung-disease-management-strategies-for-advanced-practice-providers-2/?utm_source=sms

12:30-1:45 pm PST 

Register & access links to the sessions at this link, https://uw.cloud-cme.com/CardiometabolicECHO

LIVE BI-MONTHLY WEBINARS:
Wednesdays @ 12:30 - 1:45 pm PST 

ECHO MS increases the capacity of neurologists and other healthcare providers to diagnose and manage individuals with multiple sclerosis. This CME program follows Project ECHO’s evidence-based tele-mentoring model and establishes a peer-to-peer knowledge sharing network. Each ECHO MS session features a brief didactic and two case discussions. The goal of ECHO MS is to improve overall health outcomes for individuals with MS.

• Mountain Hub – Rocky Mountain MS Center at the University of Colorado
  • 1st & 3rd Thursdays | 12:00 – 1:00 PM MT | Sept. 15, 2022 – Mar. 2, 2023 (12 CME)

REGISTER HERE: https://secure.nationalmssociety.org/site/SSurvey;jsessionid=00000000.app30052a?NONCE_TOKEN=588242FF986DCBB0F63BBEED65E468CF&ACTION_REQUIRED=URI_ACTION_USER_REQUESTS&SURVEY_ID=95853

The AMA has a portal of opioid-related CME courses.

Click here to access the portal:
https://edhub.ama-assn.org/pages/opioid-cme-course